D-GL conjugate therapy
US5017648A · kind A · utility
5Cited by
6References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 10, 1990 |
| Grant date | May 21, 1991 |
| Priority date | — |
| Expiry date | Aug 10, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2121/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Receptor blocking technology using proteins conjugated to polymers of D-glutamic acid and D-lysine for treatment of antibody-mediated autoimmune disease, membrane and tumor disorders is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.